Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) is now available.
Resmed Inc has filed a notice of proposed sale of securities under Rule 144, indicating that Michael J. Rider, an officer of the company, plans to sell 66 shares of common stock. This filing is part of a series of transactions, with previous sales occurring in April and June 2025, reflecting ongoing stock management by company insiders. The sales are executed through Fidelity Brokerage Services LLC, and the transactions are part of restricted stock vesting, highlighting routine financial activities within the company.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$37.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
Resmed Inc operates in the healthcare industry, primarily focusing on the development and manufacturing of products related to sleep disorders and respiratory care. The company is known for its innovative solutions in sleep apnea treatment and other respiratory conditions, serving a global market with a strong emphasis on improving patient outcomes.
Average Trading Volume: 1,161,681
Technical Sentiment Signal: Buy
Current Market Cap: A$57.03B
For an in-depth examination of RMD stock, go to TipRanks’ Overview page.